South Korea Menopause Market Size & Outlook, 2024-2030

The menopause market in South Korea is expected to reach a projected revenue of US$ 606.2 million by 2030. A compound annual growth rate of 6.9% is expected of South Korea menopause market from 2025 to 2030.
Revenue, 2024 (US$M)
$416.1
Forecast, 2030 (US$M)
$606.2
CAGR, 2025 - 2030
6.9%
Report Coverage
South Korea

South Korea menopause market highlights

  • The South Korea menopause market generated a revenue of USD 375.8 million in 2022 and is expected to reach USD 606.2 million by 2030.
  • The South Korea market is expected to grow at a CAGR of 6.2% from 2023 to 2030.
  • In terms of segment, dietary supplements was the largest revenue generating treatment in 2022.
  • Dietary Supplements is the most lucrative treatment segment registering the fastest growth during the forecast period.


Menopause market data book summary

Market revenue in 2022USD 375.8 million
Market revenue in 2030USD 606.2 million
Growth rate6.2% (CAGR from 2022 to 2030)
Largest segmentDietary supplements
Fastest growing segmentDietary Supplements
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationOTC pharma products, Dietary Supplements
Key market players worldwideBayer AG, AbbVie Inc, Abbott Laboratories, Nestle SA, Dr Reddy's Laboratories Ltd ADR, Theramex, Rainbow Light Nutritional Systems, Padagis


Other key industry trends

  • In terms of revenue, South Korea accounted for 2.3% of the global menopause market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China menopause market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,632.2 million by 2030.

Dietary supplements was the largest segment with a revenue share of 95.93% in 2024. Horizon Databook has segmented the South Korea menopause market based on otc pharma products, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.


Around 70% of Korean women experience hot flashes, making it the most commonly experienced symptom. 60% of women experiencing hot flashes reported experiencing the symptom prior to onset of menopause. Manufacturers are adopting patented technologies for the development of supplements.

In January 2021, Korea Yakult launched fermented red ginseng to improve the immune system and ease menopausal symptoms in middle-aged women. The red ginseng fermentation was performed using a technology patented in 2019. Increasing the availability of products can help meet the growing demand for dietary supplements in the country.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Menopause Market Scope

Menopause market segmentation & scope
Hormonal
Non-Hormonal
Dietary Supplements
Countries
UK
Sweden
Norway
Denmark
Australia
Thailand
Argentina
Saudi Arabia
UAE
Kuwait

Menopause Market Companies

Name Profile # Employees HQ Website

South Korea menopause market size, by treatment, 2018-2030 (US$M)

South Korea Menopause Market Outlook Share, 2024 & 2030 (US$M)

South Korea menopause market size, by treatment, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more